24/7 Market News Snapshot 31 July, 2025 – FOXO Technologies Inc. (NYSE:FOXO)

July 31, 2025

DENVER, Colo., 31 July, 2025 (www.247marketnews.com) – (NYSE:FOXO) are discussed in this article.
FOXO Technologies Inc. is currently facing a challenging market phase, trading at $0.179 in the pre-market session, which signifies a decline of approximately 4.18% from its previous close of $0.187. The heightened trading volume of 12.61 million shares indicates increased investor activity, possibly reflecting selling pressure influenced by broader market conditions or specific developments within the company. Key support levels to monitor are around $0.170, while resistance is observed near $0.190. Traders are advised to keep a close watch on volume patterns and price movements, as they could signal potential reversals or further declines in the near term.

In contrast, FOXO Technologies has recently achieved a pivotal milestone by successfully renewing the operating license for its behavioral health subsidiary, Myrtle Recovery Centers, Inc. This renewal, resulting from a favorable inspection by regulatory authorities, enables Myrtle to continue its operations at its residential treatment facility focused on alcohol and drug recovery. The Oneida location has reached full capacity, highlighting the increasing demand for effective substance abuse treatment services, and currently has a waiting list for admissions, illustrating its dedication to providing quality behavioral health support.

Robert Merritt, CEO of Myrtle Recovery Centers, expressed contentment with the renewal, stating, “We are pleased that the state renewed our operating license for another year.” Seamus Lagan, CEO of FOXO Technologies, outlined the company’s strategic plans for growth, indicating that the success of Myrtle’s initial location may lead to the establishment of a second facility and the exploration of potential acquisitions within the sector.

This renewal represents a significant step in FOXO Technologies’ overarching mission to deliver innovative solutions in healthcare and biotechnology. As the company continues to bolster its initiatives and expand its reach, it remains steadfast in its commitment to improving health outcomes in the communities it serves.

Related news for (FOXO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.